Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis. | Cancer Cell Int | 2021 | 33858415 | PubTator, text mining | PubMed |
| Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer. | J Cancer | 2021 | 33854619 | PubTator, text mining | PubMed |
| Deciphering Myostatin's Regulatory, Metabolic, and Developmental Influence in Skeletal Diseases. | Front Genet | 2021 | 33854530 | PubTator, text mining | PubMed |
| The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypoparathyroidism-A Randomized Crossover Study. | J Bone Miner Res | 2021 | 33852173 | PubTator, text mining | PubMed |
| Discovery of bone morphogenetic protein 7-derived peptide sequences that attenuate the human osteoarthritic chondrocyte phenotype. | Mol Ther Methods Clin Dev | 2021 | 33850953 | PubTator, text mining | PubMed |
| Active search of adult patients with persistently low serum alkaline phosphatase levels for the diagnosis of hypophosphatasia. | Arch Endocrinol Metab | 2021 | 33844893 | PubTator, text mining | PubMed |
| Co-cultivation of progenitor cells enhanced osteogenic gene expression and angiogenesis potential in vitro. | J Int Med Res | 2021 | 33840248 | PubTator, text mining | PubMed |
| Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma. | Front Oncol | 2021 | 33833982 | PubTator, text mining | PubMed |
| Clinical and genetic characteristics of hypophosphatasia in Chinese children. | Orphanet J Rare Dis | 2021 | 33827627 | PubTator, text mining | PubMed |
| GSK3β rephosphorylation rescues ALPL deficiency-induced impairment of odontoblastic differentiation of DPSCs. | Stem Cell Res Ther | 2021 | 33823913 | PubTator, text mining | PubMed |
| Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia. | J Clin Pharmacol | 2021 | 33822385 | PubTator, text mining | PubMed |
| Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial. | Elife | 2021 | 33821793 | PubTator, text mining | PubMed |
| Novel mutation in the ALPL gene with a dominant negative effect in a Japanese family. | J Bone Miner Metab | 2021 | 33821301 | Swiss-Prot, curated | PubMed |
| Possible Implications for Improved Osteogenesis? The Combination of Platelet-Rich Fibrin With Different Bone Substitute Materials. | Front Bioeng Biotechnol | 2021 | 33816452 | PubTator, text mining | PubMed |
| Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa. | Mol Genet Metab | 2021 | 33814268 | PubTator, text mining | PubMed |
| ZnO Nanosheet-Coated TiZrPdSiNb Alloy as a Piezoelectric Hybrid Material for Self-Stimulating Orthopedic Implants. | Biomedicines | 2021 | 33808338 | PubTator, text mining | PubMed |
| MPscore: A Novel Predictive and Prognostic Scoring for Progressive Meningioma. | Cancers (Basel) | 2021 | 33807688 | PubTator, text mining | PubMed |
| Surface Modifications of Titanium Aluminium Vanadium Improve Biocompatibility and Osteogenic Differentiation Potential. | Materials (Basel) | 2021 | 33807039 | PubTator, text mining | PubMed |
| Single-Shot Vaccines against Bovine Respiratory Syncytial Virus (BRSV): Comparative Evaluation of Long-Term Protection after Immunization in the Presence of BRSV-Specific Maternal Antibodies. | Vaccines (Basel) | 2021 | 33803302 | PubTator, text mining | PubMed |
| Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides. | Int J Mol Sci | 2021 | 33802220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=65